The expression of CLCF1, AEBP1, and OS9 is significantly associated with the prognosis of PTEN-wt glioma, indeed which are significantly different between high-risk score patients and low-risk patients in the PTEN-mut subgroup (Figures 4G–I, p < 0.001). Here, CLCF1 is linked to central nervous system cancer.